INHIBITING MDSC BIOGENESIS TO AUGMENT IMMUNOTHERAPY EFFICACY IN TRIPLE-NEGATIVE BREAST CANCER

$1,301,250FY2025Defense Health AgencyDOD

Health Research, Inc., Rockville MD

Investigators